# Ketorolac Tromethamine Injection: FDA shortage status > FDA source status only. Nationwide status is not local pharmacy inventory. This page does not provide medical, treatment, substitution, or dosing advice. - Derived status: current - Source statuses: Current - FDA package records: 25 - Latest FDA row update: 08/18/2026 - Retrieved: 2026-08-22T15:54:11+00:00 ## FDA package and manufacturer records - Alembic Pharmaceuticals — Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 62332-599-25) — FDA availability: Available — updated: 05/15/2026 - Alembic Pharmaceuticals — Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 62332-600-25) — FDA availability: Available — updated: 05/15/2026 - Alembic Pharmaceuticals — Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 62332-601-25) — FDA availability: Available — updated: 05/15/2026 - Baxter Healthcare — Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0338-0069-10) — FDA availability: Unavailable — updated: 08/17/2026 - Baxter Healthcare — Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0338-0072-25) — FDA availability: Unavailable — updated: 08/17/2026 - Fresenius Kabi USA, LLC — Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 63323-161-01) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 76045-107-10) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-01) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-02) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 76045-104-10) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 76045-105-20) — FDA availability: Unavailable — updated: 08/04/2026 - Gland Pharma Limited — Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01) — FDA availability: Available — updated: 07/22/2026 - Gland Pharma Limited — Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01) — FDA availability: Available — updated: 07/22/2026 - Gland Pharma Limited — Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02) — FDA availability: Available — updated: 07/22/2026 - Gland Pharma Limited — Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-118-25) — FDA availability: Available — updated: 07/22/2026 - Gland Pharma Limited — Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-119-25) — FDA availability: Available — updated: 07/22/2026 - Hikma Pharmaceuticals USA, Inc. — Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0641-6041-25) — FDA availability: Unavailable — updated: 08/13/2026 - Hikma Pharmaceuticals USA, Inc. — Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6042-25) — FDA availability: Unavailable — updated: 08/13/2026 - Hikma Pharmaceuticals USA, Inc. — Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6043-25) — FDA availability: Unavailable — updated: 08/13/2026 - Hospira, Inc., a Pfizer Company — Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0409-3793-01) — FDA availability: Unavailable — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0409-3795-01) — FDA availability: Unavailable — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Ketorolac Tromethamine, Injection, 60 mg/2 mL (30 mg/mL) (NDC 0409-3796-01) — FDA availability: Unavailable — updated: 08/07/2026 - Sagent Pharmaceuticals — Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01) — FDA availability: Limited Availability — updated: 08/18/2026 - Sagent Pharmaceuticals — Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01) — FDA availability: Available — updated: 08/18/2026 - Sagent Pharmaceuticals — Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02) — FDA availability: Available — updated: 08/18/2026 ## Sources and formats - [FDA openFDA source](https://api.fda.gov/drug/shortages.json) - [Canonical HTML](https://citefacts.com/shortages/ketorolac-tromethamine-injection) - [JSON record](https://citefacts.com/shortages/ketorolac-tromethamine-injection.json)